Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study (Q82709302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Giuseppe Pantaleo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Samantha Jilek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Emilie Jaquiéry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hans H Hirsch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Andreas Lysandropoulos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mathieu Canales

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Laurence Guignard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Myriam Schluep

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

29 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

264-272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

Immunology of multiple sclerosis

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Seroepidemiology of the human polyomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

1 reference

7 January 2021

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Natalizumab: bound to rebound?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Asymptomatic reactivation of JC virus in patients treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970006-5

7 January 2021

10.1016/S1474-4422(10)70006-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117055%20AND%20SRC:MED&resulttype=core&format=json